A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

August 31, 2013

Conditions

Healthy

Interventions

DRUG

GL2907

once a day

DRUG

Oxycontine CR 10mg

twice a day

Trial Locations (1)

AJOU University Hospital, Suwon